Cargando…

Need to Face Liver Cirrhosis after HCV Cure with Antivirals

Detalles Bibliográficos
Autores principales:	Soriano, Vicente, Benitez, Laura, Arias, Ana, Barreiro, Pablo, de Mendoza, Carmen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5651974/ https://www.ncbi.nlm.nih.gov/pubmed/28916156 http://dx.doi.org/10.1016/j.ebiom.2017.08.022

Ejemplares similares

HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients
por: Brochado-Kith, Óscar, et al.
Publicado: (2021)

Antiviral Therapy in Chronic Hepatitis C Virus-related Decompensated Liver Cirrhosis – A Tightrope Walk
por: Amarapurkar, Deepak N.
Publicado: (2010)

Direct-Acting Antivirals for HCV Treatment in Decompensated Liver Cirrhosis Patients: A Systematic Review and Meta-Analysis
por: An, JiHyun, et al.
Publicado: (2022)

Risk of adverse outcomes following treatment with direct acting antiviral drugs in HCV infected patients with liver cirrhosis
por: Riaz, Hafiza Arooba, et al.
Publicado: (2023)

Telomere Length Increase in HIV/HCV-Coinfected Patients with Cirrhosis after HCV Eradication with Direct-Acting Antivirals (†)
por: Molina-Carrión, Silvia, et al.
Publicado: (2020)

Relationship of TRIM5 and TRIM22 polymorphisms with liver disease and HCV clearance after antiviral therapy in HIV/HCV coinfected patients
por: Medrano, Luz M., et al.
Publicado: (2016)

The Changing Face of Liver Transplantation in the United States: The Effect of HCV Antiviral Eras on Transplantation Trends and Outcomes
por: Parrish, Nicholas F., et al.
Publicado: (2019)

Screening and surveillance of oesophageal varices in patients with HCV‐positive liver cirrhosis successfully treated by direct‐acting antiviral agents
por: Ciancio, Alessia, et al.
Publicado: (2022)

Use of antibiotics in respiratory viral infections
por: Fernández-Montero, José Vicente, et al.
Publicado: (2022)

Implications of BMP9/10 for patients with liver cirrhosis
por: Ji, Dong, et al.
Publicado: (2020)

Hepatocyte Turnover in Chronic HCV-Induced Liver Injury and Cirrhosis
por: Karidis, Nikolaos P., et al.
Publicado: (2015)

Liver Remodeling on CT Examination in Patients with HCV Compensated Cirrhosis Who Achieved Sustained Virological Response after Direct-Acting Antivirals Treatment
por: Mihai, Florin, et al.
Publicado: (2020)

GLP-2 cures the gut – What about the liver?
por: Pakarinen, Mikko P.
Publicado: (2019)

Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured HCV infection
por: Innes, Hamish, et al.
Publicado: (2021)

Direct-Acting Antivirals Improve Access to Care and Cure for Patients With HIV and Chronic HCV Infection
por: Collins, Lauren F, et al.
Publicado: (2017)

Successful and Safe Long-Term Standard Antiviral Therapy in a Patient with “Explosive” Immune Response in Course of HCV-Related Liver Cirrhosis
por: Conca, Paolo, et al.
Publicado: (2015)

Prognostic value of liver stiffness in HIV/HCV-Coinfected patients with decompensated cirrhosis
por: Pérez-Latorre, Leire, et al.
Publicado: (2018)

An Ounce of Tat Prevention Is Worth a Pound of Functional Cure
por: Planelles, Vicente
Publicado: (2015)

HCV cure without interferon
por: Bourlière, Marc
Publicado: (2014)

Ultra-long-acting (XLA) antivirals for chronic viral hepatitis
por: Soriano, Vicente, et al.
Publicado: (2022)

Transplantation of HCV Viremic Livers into HCV Viremic Recipients Followed by Direct-acting Antiviral Therapy
por: Kapila, Nikhil, et al.
Publicado: (2019)

Ethical concerns facing abortion researchers in restrictive settings: the need for guidelines
por: Kimemia, Grace W., et al.
Publicado: (2023)

No strategy to meet the HCV epidemic
por: Dalgard, Olav, et al.
Publicado: (2014)

Can Hepatitis C Virus (HCV) Direct-Acting Antiviral Treatment as Prevention Reverse the HCV Epidemic Among Men Who Have Sex With Men in the United Kingdom? Epidemiological and Modeling Insights
por: Martin, Natasha K., et al.
Publicado: (2016)

The needs and concerns of clinical educators in radiography education in the face of COVID-19 pandemic
por: Tay, Yi Xiang, et al.
Publicado: (2021)

Silent damage? Occult HCV replication and histological disease may occur following apparent HCV clearance
por: Manickam, Cordelia, et al.
Publicado: (2019)

Guidelines Have a Key Role in Driving HCV Elimination by Advocating for Simple HCV Care Pathways
por: Mangia, Alessandra, et al.
Publicado: (2021)

Bleeding risk and thrombosis in cirrhosis: a paradox with a need to address them
por: Kulkarni, Anand V., et al.
Publicado: (2023)

Key Milestones in HCV Discovery and Therapeutics
por: Cheng, Xiaoming, et al.
Publicado: (2020)

Prioritizing sexual and reproductive health in the face of competing health needs: where are we going?
por: Otu, Akaninyene, et al.
Publicado: (2021)

Human albumin infusion strategy in liver cirrhosis: liberal or restrictive?
por: Bai, Zhaohui, et al.
Publicado: (2021)

A painful lesson from the COVID-19 pandemic: the need for broad-spectrum, host-directed antivirals
por: Chitalia, Vipul C., et al.
Publicado: (2020)

No impact of IL28B polymorphisms on liver enzymes in patients coinfected with HIV and HCV
por: Fernández-Montero, JV, et al.
Publicado: (2010)

Early changes in brain structure, functional connectivity and neuropsychiatric symptoms after HCV infection cure with direct-acting antivirals
por: Cavero, M., et al.
Publicado: (2021)

Real-Life Early Anthropometric, Lipid and Liver Changes after Direct-Acting Antiviral Therapy in PLWHIV with HCV Co-Infection
por: Ferra-Murcia, Sergio, et al.
Publicado: (2022)

HCV cure for everyone or which challenges remain?
por: Rockstroh, Jürgen Kurt
Publicado: (2015)

Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells
por: Plumlee, Courtney R, et al.
Publicado: (2005)

Analysis of Effect of Antiviral Therapy on Regression of Liver Fibrosis in Patient with HCV Infection
por: Vukobrat-Bijedic, Zora, et al.
Publicado: (2014)

Third wave of COVID-19 in Madrid, Spain
por: Soriano, Vicente, et al.
Publicado: (2021)

Tivozanib in advanced inoperable hepatocellular carcinoma: considerations for patients with liver cirrhosis
por: Oh, Hyunwoo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qtvulmocek0lsqq9oqv399d0kj